Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Apr;72(1):124–129.

Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

R Paganelli 1, M R Capobianchi 1, B Ensoli 1, G P D'Offizi 1, J Facchini 1, F Dianzani 1, F Aiuti 1
PMCID: PMC1541514  PMID: 3135128

Abstract

We have selected 11 patients with primary immunodeficiency disorders predominantly affecting T lymphocyte function (four with ataxia-telangiectasia (AT), four with common variable immunodeficiency (CVI) and one each with Wiskott-Aldrich syndrome, hyper-IgE syndrome and combined immunodeficiency) with defective gamma interferon (IFN-gamma) production in vitro. Induction with phytohaemagglutinin showed low interleukin 2 (IL-2) production concomitant with reduced IFN-gamma titres. However the addition of 10 U/ml of rIL-2 to cultures stimulated with staphylococcal enterotoxin B or galactose oxidase failed to restore IFN-gamma production in defective cases. IFN-gamma was titrated by both bioassay and immunoradiometric assay, ruling out the possible release of inactive or altered IFN-gamma molecules. Normal levels of IFN-gamma were found in patients of patients with AT, as well as in two AT and two CVI cases, demonstrating heterogeneity of defects within these syndromes. Soluble inhibitors or cellular suppression of IFN-gamma were not observed in mixing experiments. The possibility that defective interaction between accessory cells and T lymphocytes might account for the poor response to the inducing agents was ruled out as no IFN-gamma was produced using a calcium ionophore--which bypasses this step--in seven patients with absolute IFN-gamma deficiency.

Full text

PDF
127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arya S. K., Gallo R. C. Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8691–8695. doi: 10.1073/pnas.82.24.8691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chang T. W., McKinney S., Liu V., Kung P. C., Vilcek J., Le J. Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5219–5222. doi: 10.1073/pnas.81.16.5219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dianzani F., Monahan T. M., Georgiades J., Alperin J. B. Human immune interferon: induction in lymphoid cells by a calcium ionophore. Infect Immun. 1980 Aug;29(2):561–563. doi: 10.1128/iai.29.2.561-563.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Farrar W. L., Johnson H. M., Farrar J. J. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol. 1981 Mar;126(3):1120–1125. [PubMed] [Google Scholar]
  5. Fiorilli M., Businco L., Pandolfi F., Paganelli R., Russo G., Aiuti F. Heterogeneity of immunological abnormalities in ataxia-telangiectasia. J Clin Immunol. 1983 Apr;3(2):135–141. doi: 10.1007/BF00915484. [DOI] [PubMed] [Google Scholar]
  6. Fiorilli M., Carbonari M., Crescenzi M., Russo G., Aiuti F. T-cell receptor genes and ataxia telangiectasia. Nature. 1985 Jan 17;313(5999):186–186. doi: 10.1038/313186a0. [DOI] [PubMed] [Google Scholar]
  7. Fiorilli M., Russo G., Paganelli R., Papetti C., Carbonari M., Crescenzi M., Calvani M., Quinti I., Aiuti F. Hypogammaglobulinemia with hyper-IgM, severe T-cell defect, and abnormal recirculation of OKT4 lymphocytes in a girl with chronic lymphadenopathy. Clin Immunol Immunopathol. 1986 Feb;38(2):256–264. doi: 10.1016/0090-1229(86)90143-1. [DOI] [PubMed] [Google Scholar]
  8. Frasca D., Adorini L., Landolfo S., Doria G. Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production. J Immunol. 1985 Jun;134(6):3907–3911. [PubMed] [Google Scholar]
  9. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  10. Greene W. C., Leonard W. J. The human interleukin-2 receptor. Annu Rev Immunol. 1986;4:69–95. doi: 10.1146/annurev.iy.04.040186.000441. [DOI] [PubMed] [Google Scholar]
  11. Imboden J. B., Weiss A., Stobo J. D. The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J Immunol. 1985 Feb;134(2):663–665. [PubMed] [Google Scholar]
  12. Jaspers N. G., Bootsma D. Genetic heterogeneity in ataxia-telangiectasia studied by cell fusion. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2641–2644. doi: 10.1073/pnas.79.8.2641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kappler J. W., Skidmore B., White J., Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med. 1981 May 1;153(5):1198–1214. doi: 10.1084/jem.153.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kasahara T., Hooks J. J., Dougherty S. F., Oppenheim J. J. Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol. 1983 Apr;130(4):1784–1789. [PubMed] [Google Scholar]
  15. Kruger G., Welte K., Ciobanu N., Cunningham-Rundles C., Ralph P., Venuta S., Feldman S., Koziner B., Wang C. Y., Moore M. A. Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. J Clin Immunol. 1984 Jul;4(4):295–303. doi: 10.1007/BF00915297. [DOI] [PubMed] [Google Scholar]
  16. Lewis D. B., Larsen A., Wilson C. B. Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J Exp Med. 1986 Apr 1;163(4):1018–1023. doi: 10.1084/jem.163.4.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. López-Botet M., Fontán G., Garcia Rodriguez M. C., de Landázuri M. O. Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies. J Immunol. 1982 Feb;128(2):679–683. [PubMed] [Google Scholar]
  18. Matricardi P. M., Capobianchi M. R., Paganelli R., Facchini J., Sirianni M. C., Seminara R., Dianzani F., Aiuti F. Interferon production in primary immunodeficiencies. J Clin Immunol. 1984 Sep;4(5):388–394. doi: 10.1007/BF00917142. [DOI] [PubMed] [Google Scholar]
  19. Murray H. W., Welte K., Jacobs J. L., Rubin B. Y., Mertelsmann R., Roberts R. B. Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. J Clin Invest. 1985 Nov;76(5):1959–1964. doi: 10.1172/JCI112194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Paganelli R., Aiuti F., Beverley P. C., Levinsky R. J. Impaired production of interleukins in patients with cell-mediated immunodeficiencies. Clin Exp Immunol. 1983 Feb;51(2):338–344. [PMC free article] [PubMed] [Google Scholar]
  21. Paganelli R., Capobianchi M. R., Matricardi P. M., Cioè L., Seminara R., Dianzani F., Aiuti F. Defective interferon-gamma production in ataxia-telangiectasia. Clin Immunol Immunopathol. 1984 Sep;32(3):387–391. doi: 10.1016/0090-1229(84)90282-4. [DOI] [PubMed] [Google Scholar]
  22. Pandolfi F., Capobianchi M., Matricardi P., Facchini J., Bonomo G., De Rossi G., Semenzato G., Fiorilli M., Dianzani F., Aiuti F. Impaired gamma interferon production by cells from patients with lymphoproliferative disorders of mature T and NK cells. Scand J Immunol. 1985 Apr;21(4):315–320. doi: 10.1111/j.1365-3083.1985.tb01436.x. [DOI] [PubMed] [Google Scholar]
  23. Reem G. H., Yeh N. H. Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes. Science. 1984 Jul 27;225(4660):429–430. doi: 10.1126/science.6429853. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES